When Miami-Dade County’s public health system unveils its new rehabilitation hospital next month, one of the first facilities built with the 2013 “miracle bond” issue, the four-story building will feature a state-of-the-art aquatic therapy pool, a physical therapy room with high-tech body-weight-supporting harnesses built into a track on the ceiling — and a $400,000 cat sculpture. More
Are rich hospitals spending as much as they should on charity care? A new analysis suggests they could be doing much more. More
A new research letter in JAMA finds that private equity ownership of specialty practices more than doubled from 2013-2016. More
Lown Institute's Vikas Saini, president, and Shannon Brownlee, senior vice president, discuss the latest Shkreli Awards winners on the Relentless Health Value podcast. More
On the Relentless Health Value podcast, Shannon Brownlee and Vikas Saini discuss this year's Shkreli Award winners. More
A recent New York Times investigation revealed that retail pharmacies are pressuring pharmacists to fill prescriptions at an unsafe pace, leading to overprescribing and medication errors. More
While doctors and hospitals chafe at the administrative burden, insurers contend the review is necessary to ferret out waste in a system whose costs are exploding and to ensure physicians are prescribing useful treatments. More
Rogue stem cell clinics continue to victimize hopeful patients seeking cures for cancer, Parkinson’s disease, autism, chronic pain, and more. More
Affordability is one of the most important considerations for hospital patients. So why isn't billing taken into account in hospital evaluations? More
Many physicians see drug samples as a benefit, because they can give pills to patients who may not be able to afford the medication otherwise. But are these "free" samples really free? More
For many, 5-minute fix is anything but More
The Lown Institute recently announced its 3rd round of “Shkreli Awards”, a top ten list of the worst examples of dysfunction in healthcare. More
Epic, the nation’s largest electronic health record (EHR) company and a major beneficiary of a $48 billion Obama-era federal program to promote the adoption of EHRs, has launched a full-scale effort to block the flow of data out of its software and into apps that benefit doctors and patients. That’s wrong for many reasons. More
Amid ongoing debate over the role the pharmaceutical industry plays in shaping health policy, a new analysis finds that patient groups funded by drug makers generally support corporate interests, few groups have policies governing industry backing, and transparency is often lacking. More
Despite two recent federal laws meant to bring parity between mental and physical health-care coverage, gaping holes remain in how behavioral health costs are paid. More
At the same time that more doctors were prescribing stimulants, a new analysis finds that 1 in 18 U.S. physicians received some form of payment from drug companies that were marketing these medicines, notably ADHD pills often prescribed for children. And the researchers suggested the financial ties may have partly contributed to the rise in prescriptions. More
Treatment at a military hospital can leave you tens of thousands of dollars in debt—and hounded by the federal government. More
For 20 years, the U.S. government has urged companies, universities, and other institutions that conduct clinical trials to record their results in a federal database, so doctors and patients can see whether new treatments are safe and effective. Few trial sponsors have consistently done so, even after a 2007 law made posting mandatory for many trials registered in the database. More
The Shkreli Awards shine a light on some of the bad behavior in the healthcare sphere during 2019. Hospitals earned four of the 10 awards from the Lown Institute. More